vimarsana.com

Latest Breaking News On - Endurant capital management - Page 1 : vimarsana.com

Atom Investors LP Has $686,000 Stock Position in Insmed Incorporated (NASDAQ:INSM)

Atom Investors LP increased its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 75.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,224 shares of the biopharmaceutical company’s stock after buying an additional 17,293 shares during the period. […]

Leerink Partnrs Analysts Cut Earnings Estimates for BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX – Free Report) – Investment analysts at Leerink Partnrs cut their Q3 2023 earnings per share estimates for BioNTech in a research note issued on Monday, August 7th. Leerink Partnrs analyst D. Graybosch now anticipates that the company will earn $0.28 per share for the quarter, down from their previous estimate of […]

BioAtla s (BCAB) Market Outperform Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $12.00 price target on the stock. Other research analysts have also recently issued research reports about the stock. EF Hutton Acquisition Co. I restated a buy rating […]

BioNTech SE (NASDAQ:BNTX) Sees Significant Decline in Short Interest

BioNTech SE (NASDAQ:BNTX – Get Free Report) saw a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 1,800,000 shares, a drop of 9.1% from the June 30th total of 1,980,000 shares. Based on an average daily volume of 691,900 shares, the short-interest ratio is […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.